Nebenwirkungen · Rivastigmine 1 A Pharma
Rivastigmine 1 A Pharma 2 mg/ml oral solution · Abschnitt 4.8 · PDF-Seite 22
HOS-212459 · Präparat HOS-154894
Infections and infestations Very rare Urinary infection Metabolism and nutrition disorders Very common Anorexia Common Decreased appetite Not known Dehydration Psychiatric disorders Common Agitation Common Confusion Common Anxiety Common Nightmares Uncommon Insomnia Uncommon Depression Very rare Hallucinations Not known Aggression, restlessness Nervous system disorders Very common Dizziness Common Headache Common Somnolence Common Tremor Uncommon Syncope Rare Seizures Very rare Extrapyramidal symptoms (including worsening of Parkinson’s disease) Not Known Pleurothotonus (Pisa syndrome) Cardiac disorders Rare Angina pectoris Very rare Cardiac arrhythmia (e.g. bradycardia, atrio- ventricular block, atrial fibrillation and tachycardia) Not known Sick sinus syndrome
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-20T13:50:00Z · SHA-256 131a9504ea601ff9f929650be1df38b3f3e958ac8aed8146800bb83c92474fa3 · Passage a881f035c1f0727910f92e0f55cf0c8806f9f8d771e13b3f868a298595dbb3b7 · Zeichen 940–2741 im Abschnitt